Trademark Overview
On Monday, June 22, 2026, a trademark application was filed for IRAC with the United States Patent and Trademark Office. The USPTO has given the IRAC trademark a serial number of 99897042. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 22, 2026. This trademark is owned by ABION Inc.. The IRAC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for suppressing tumors; Vaccines; Vaccine preparations; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; Pharmaceutical preparations for the treatment of viral diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Biological preparations for the prevention and treatment of cancer; Pharmaceutical preparations, namely, antivirals
Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Technical research in the field of pharmaceutical studies; Development of pharmaceutical preparations and medicines; Scientific research for medical purposes in the field of cancerous diseases; Medical research; Providing scientific research information in the field of pharmaceuticals; Scientific study and research in the field(s) of medicine; Research and development services in the field of medical preparations; Research and development of new products in the field of pharmaceuticals
